Pharma Focus Asia
KP - Sustainable Packaging Solutions

Latest Issue
Get instant access to latest e-book

LATEST NEWS


Feb 2024

Rhythm Pharmaceuticals Reveals Clinical Development Strategy for Setmelanotide in Addressing Hypothalamic Obesity in Japan

Rhythm Pharmaceuticals Inc a global commercialstage biopharmaceutical company specializing in rare neuroendocrine diseases has announced plans to expand its ongoing global Phase clinical trial


Feb 2024

Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®

Ligand Pharmaceuticals Incorporated has announced that Eisai Co Ltd its partner has received approval for the injection formulation of their antiepileptic drug Fycompa


Feb 2024

WuXi Advanced Therapies Receives FDA Approval for Manufacturing Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

WuXi Advanced Therapies a subsidiary of WuXi AppTec has received approval from the US Food and Drug Administration to initiate analytical testing and manufacturing of AMTAGVI for Iovance


Feb 2024

Dyadic Strengthens Collaboration with Israel Institute for Biological Research (IIBR) to Address Bio-Threats and Emerging Disease Solutions

Dyadic International Inc a prominent biotechnology firm specializing in advanced microbial platforms for protein development and bioproduction has announced a significant advancement


Feb 2024

Immuneering's IMM-1-104 Receives FDA Fast Track Designation for Pancreatic Cancer

Immuneering Corporation has recently announced that the US Food and Drug Administration granted Fast Track designation for its lead clinicalstage program IMM targeting patients with pancreatic


Feb 2024

Mabwell's Innovative B7-H3 ADC 7MW3711 Receives FDA IND Approval

Mabwell an innovative biopharmaceutical company with a comprehensive industry chain recently announced the approval of its clinical trial application by the US Food and Drug Administration for BH targeting ADC designed for advanced malignant solid tumors


press releases


Feb 2024

OVID Health launches 2024 Patient Partnership Index showcasing gold standard patient-centric care

Leading independent health communications consultancy OVID Health have announced the opening of their innovative Patient Partnership Index the only international initiative which recognizes


Feb 2024

Immunofoco Announces the Dual Approval of IND Applications by the U.S. FDA and China CDE for the First EpCAM CAR-T Targeted at Advanced Solid Tumors

Immunofoco a company dedicated to developing cell therapy products for solid tumors announced a significant milestone that following the approval by the CDE in China for the clinical trial application of IMC an EpCAMtargeting autologous CART cell product for infusion


Feb 2024

Gracell Biotechnologies Acquisition Completed

Gracell Biotechnologies Inc a global clinicalstage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune disease today announced the completion of its previously announced agreement to be acquired by Astra


Feb 2024

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

Elevation Oncology Inc an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical


Feb 2024

Everest Medicines’ Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis

Everest Medicines partner Pfizer Inc announced that the European Commission has granted marketing authorization for VELSIPITY in the European Union to treat patients years of age and older with


Feb 2024

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

Servier a global leader in oncology focused on delivering meaningful therapeutic progress for the patients it serves today announced the FDA filing acceptance and priority review for a New Drug Application

25 - 27

Feb 2024

26 - 28

Feb 2024

26 - 27

Feb 2024

3rd Rx-to-OTC Switch

Pennsylvania, USA

27 - 28

Feb 2024

29 - 01

Feb 2024

Biomarkers 2024

London, UK

03 - 05

Mar 2024

Saudi Rehab Expo

Riyadh, Saudi Arabia

Standard BioTools™
MFA + MMA 2024
Gibco Adherent Kidney Media Panel
TFS - ODW - The Technology Debate: Single-Use vs. Stainless Steel
Equinix accelerated medical research...
Thermofisher - Antibody Therapeutic Polishing
Searching for an end-to-end patient tech solution?


  • 2

    Homeopathic Science

    Aditya Dilipkumar Patil

    Assistant Professor, Department of Homoeopathic Pharmacy, Dr.D.Y.Patil Homoeopathic Medical College and Research Centre

    Parth Sanjeev Aphale

    Professor, Department of Homoeopathic Pharmacy, Dr. D Y Patil Homoeopathic Medical College and Research Centre

    Dharmendra Basudeo Sharma

    Principal, Dr. D Y Patil Homoeopathic Medical College and Research Centre

  • 4

    3D Printing Revolutionising Nanotechnology

    Mansi Athalye

    Assistant Professor , Department of Pharmaceutics at L. M. College of Pharmacy

    Sagar Popat

    Research Student, Pursuing M. Pharmacy, Pharmaceutics, L. M. College of Pharmacy

  • 5

    Approach for Producing Pharmaceuticals in Layer By Layer Fashion: Additive Manufacturing

    Lakshmi usha Ayalasomayajula

    Assistant Professor, Department of Pharmaceutical Technology, M.R. College of Pharmacy

    Earle Radha Rani

    Department of Pharmaceutics, Maharajah's College of Pharmacy

    AVS Ksheera Bhavani

    Department of Pharmaceutics, Sri Venkateswara College Of Pharmacy

    Kishore Pathivada

    Department of Pharmaceutics, Maharajah's College of Pharmacy


  • Interviews

    University of Lincoln, UK

    Senior Lecturer, School of Pharmacy

    Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy University of Lincoln Prior to Lincoln he had held many prestigious fellowships such as the Alexander von Humboldt fellowship Germany and Senior Research Fellowship DANIDA Denmark and CSIR India He is an organic chemist He has developed bioconjugations for DNA RNA and polymer modifications in water He is currently...
  • Research Insights

    Virus-derived variation in diverse human genomes

    Acquisition of genetic material from viruses by their hosts can generate interhost structural genome variation We developed computational tools enabling us to study virusderived structural variants SVs in populationscale whole genome sequencing WGS datasets and applied them to humans Although SVs had already been cataloged in these subjects